Related Experiment Video
Updated: May 3, 2026
Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
Published on: March 8, 2018
MicroRNAs: the underlying mediators of pathogenetic processes in vascular complications of diabetes
Michael Anthony Ruiz1, Subrata Chakrabarti1
1Department of Pathology, Western University, London, Ontario, Canada.
Abstract:
Diabetes mellitus causes chronic complications primarily affecting the vasculature of various organs, risking patients for renal failure, vision loss and heart failure. A newly discovered class of molecules, microRNAs, may be important in the genesis of these pathologic processes. microRNAs regulate gene expression at the post-transcriptional level by inhibiting target messenger RNA translation. In disease states, however, the expression of microRNAs often is altered, resulting in further altered expression (mostly overexpression) of downstream target genes. Interestingly, restoring microRNA expression to normal levels can correct downstream effects and prevent diabetes-associated changes. Investigations into microRNA involved in various pathogenetic processes mediating diabetic nephropathy, retinopathy and cardiomyopathy are highlighted in this review. Future directions of microRNA in therapeutics and diagnostics are also discussed. It is our intent to help the reader appreciate the diverse interactions microRNAs have in cellular signalling and how understanding epigenetic elements, such as microRNAs, potentially can yield new therapeutic strategies.
Insights
MicroRNAs (a class of molecules) play a key role in diabetes complications. Restoring normal microRNA levels can prevent or correct diabetes-associated changes in organs like the kidneys, eyes, and heart.
Area of Science:
- Molecular Biology
- Genetics
- Endocrinology
Background:
- Diabetes mellitus leads to chronic vascular complications, including renal failure, vision loss, and heart failure.
- MicroRNAs are key regulators of gene expression at the post-transcriptional level.
- Altered microRNA expression is implicated in the pathogenesis of diabetes-associated organ damage.
Purpose of the Study:
- To review the role of microRNAs in the development of diabetic nephropathy, retinopathy, and cardiomyopathy.
- To discuss the potential of microRNAs as therapeutic and diagnostic targets for diabetes complications.
- To highlight the significance of microRNAs in cellular signaling and epigenetic regulation.
Main Methods:
- Review of existing literature on microRNA function in diabetes.
- Analysis of studies investigating microRNA involvement in diabetic organ damage.
- Exploration of therapeutic and diagnostic applications of microRNAs.
Main Results:
- MicroRNA dysregulation contributes to the vascular pathology seen in diabetes.
- Restoring normal microRNA expression can reverse or prevent diabetes-associated cellular changes.
- MicroRNAs are critical mediators in the signaling pathways underlying diabetic complications.
Conclusions:
- MicroRNAs are pivotal in the pathogenesis of diabetic complications affecting the vasculature.
- Modulating microRNA expression holds promise for novel therapeutic strategies in diabetes management.
- Understanding microRNAs offers new avenues for diagnostic tools and treatments for diabetic patients.
Related Concept Videos
01:28Diabetic Nephropathy
01:27Diabetic Retinopathy
01:26Type I Diabetes II: Pathophysiology
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
01:22Complications of Diabetes Mellitus
01:24Type II Diabetes II: Pathophysiology